Artificial Intelligence gives new hope for patients with Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis is a chronic, progressive lung disease. This condition causes scar tissue (fibrosis) to build up in the lungs, which makes the lungs unable to transport oxygen into the bloodstream effectively.

Some common signs can be mentioned that are shortness of breath and a persistent dry, hacking cough. Many affected individuals also experience a loss of appetite and gradual weight loss. Some people with idiopathic pulmonary fibrosis develop widened and rounded tips of the fingers and toes (clubbing) resulting from a shortage of oxygen.

Machine learning approaches, specifically deep learning, can be used to identify, categorize, and segment interstitial lung disease (ILD) images on HRCT scans. The commonly used approach is a convolutional neural network (CNN) segmentation method, such as U-Net. Data augmentation techniques, such as flipping, rotation, cropping, and scaling, can be used to increase the amount of available training data.

By combining data augmentation and deep learning techniques, the accuracy of fibrosis morphological classification can be improved.

Machine learning algorithms can also be used to classify HRCT images of pulmonary fibrosis based on the 2011 ATS/ERS/JRS/ALAT criteria and the 2018 Fleischner Society criteria.

By correlating CALIPER-derived CT features with lung function parameters such as forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1), the software provides an objective measure of pulmonary fibrosis severity and allows monitoring treatment response.

It is important to note that some limitations and challenges exist when using machine learning for evaluating the efficacy of antifibrosis therapy in IPF patients, such as the need for large training datasets, the accurate execution of lung volume measurement, and the potential impact of radiation dose on CT-derived measures

AI can help predict disease progression and treatment outcomes by analyzing patient data and medical history. This can help clinicians make informed decisions about treatment options and enable earlier intervention to slow disease progression.

CALIPER is a machine learning tool that has been shown to be useful for tracking and forecasting disease progression in ILD patients. The tool allows for quantitative analysis of HRCT images to identify CT-sensitive characteristics that can accurately predict death in ILD patients. CALIPER parameters have also been shown to correspond well with lung function results and can be a potent and objective addition to traditional lung function proxies in the absence of confounding factors affecting lung function.

In order to evaluate 2424 subjects and forecast the severity of pulmonary fibrosis patients, Sikandar et al. [19] built and trained the Forest model. The model’s sensitivity and accuracy were 0.71 and 0.64, respectively. This model will assist medical professionals in accurately diagnosing IPF patients, determining the disease’s severity at an early stage, and taking prompt corrective action to treat IPF.

By analyzing HRCT images of patients with interstitial lung diseases (ILD). These approaches involve the use of convolutional neural networks (CNNs) like the U-Net model, which is widely employed for segmenting ILD images.

First, a dataset of HRCT images is prepared for training the deep learning model. This may include augmenting the existing data by applying various transformations like image flipping, rotation, cropping, and scaling. This data augmentation process enhances the diversity of the dataset and helps to improve the model’s performance.

Next, the training process begins, where the model learns to detect and classify different morphological features associated with pulmonary fibrosis, such as reticulation, honeycombing, and irregular linear shadows. The trained model’s accuracy is then evaluated on a separate set of HRCT images that have not been used during the training phase.

Once the model is sufficiently accurate in diagnosing and classifying pulmonary fibrosis, it can be used by clinicians to assess the severity of the disease and assist in treatment decision-making

The Forest model developed by Sikandar et al. achieved a sensitivity of 0.71 and an accuracy of 0.64 in predicting the severity of pulmonary fibrosis in patients. Such models can help clinicians make timely treatment choices and potentially avoid invasive surgical lung biopsy procedures.

Thanks for reading!

If you are finding information about machine learning, artificial intelligence or data in general or medical imaging fields. Follow us to acquire more useful knowledge about these 3 keywords.

Contact us

Email: info@vinlab.io

Related posts:

Short for Management of Assaultive Behavior, MAB is a certification course that teaches medical professionals the skills they need to manage violent behavior at every stage. Led by a certified and…

DMD 3.0 has been in place for over a year now (launched September 2017) and introduced several major improvements to the protocol’s capabilities and functionality (Extended wallet functionality…

NAMESPACE is a popular concept in many languages like C#, PHP, Ruby … Without namespace, once two classes happen to be the same name, it will not compile due to the name conflicting. That is why the…